全文获取类型
收费全文 | 9794篇 |
免费 | 893篇 |
国内免费 | 264篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 403篇 |
妇产科学 | 181篇 |
基础医学 | 976篇 |
口腔科学 | 65篇 |
临床医学 | 791篇 |
内科学 | 1553篇 |
皮肤病学 | 79篇 |
神经病学 | 343篇 |
特种医学 | 172篇 |
外国民族医学 | 1篇 |
外科学 | 2625篇 |
综合类 | 1137篇 |
现状与发展 | 4篇 |
一般理论 | 6篇 |
预防医学 | 421篇 |
眼科学 | 84篇 |
药学 | 1152篇 |
1篇 | |
中国医学 | 819篇 |
肿瘤学 | 120篇 |
出版年
2024年 | 8篇 |
2023年 | 154篇 |
2022年 | 147篇 |
2021年 | 255篇 |
2020年 | 286篇 |
2019年 | 367篇 |
2018年 | 357篇 |
2017年 | 360篇 |
2016年 | 334篇 |
2015年 | 332篇 |
2014年 | 583篇 |
2013年 | 631篇 |
2012年 | 590篇 |
2011年 | 750篇 |
2010年 | 595篇 |
2009年 | 560篇 |
2008年 | 596篇 |
2007年 | 535篇 |
2006年 | 550篇 |
2005年 | 475篇 |
2004年 | 424篇 |
2003年 | 407篇 |
2002年 | 361篇 |
2001年 | 239篇 |
2000年 | 237篇 |
1999年 | 171篇 |
1998年 | 110篇 |
1997年 | 111篇 |
1996年 | 95篇 |
1995年 | 78篇 |
1994年 | 64篇 |
1993年 | 39篇 |
1992年 | 32篇 |
1991年 | 15篇 |
1990年 | 13篇 |
1989年 | 10篇 |
1988年 | 20篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
洁泽2号预防白色念珠菌阴道炎的实验研究 总被引:2,自引:0,他引:2
目的:观察洁泽2号(JZ2)中药复方洁泽1号(JZ1)与外用杀精剂壬苯醇醚(N-9)混合制剂体外对白色念珠菌的抑菌活性及对小鼠白色念珠菌性阴道炎的预防作用。方法:采用琼脂稀释多点接触法检测最小抑菌浓度(MIC)和最小杀菌浓度(MBC);造模前阴道内按分组分别注入各药物凝胶20μl,1min后阴道接种白色念珠菌液5×104个/只,分别于造模后第2、4、7、14天观察小鼠阴道灌洗液菌丝生成及菌落计数结果,阴道、子宫组织PAS染色,各组阴道组织的炎症分值及阴道炎预防率。结果:体外实验中,JZ2对念珠菌的抑制作用较N-9好,菌液浓度为5×105个/ml时,JZ2的MIC和MBC均为1∶64(含JZ17.8mg,N-90.78mg);随着JZ2凝胶中JZ1浓度的降低,小鼠白色念珠菌性阴道炎预防率逐渐下降,呈现一定的量效关系。JZ2高剂量凝胶组预防率可达65.0%,与模型组预防率0、空白凝胶组预防率20.0%比较差异有统计学意义(P<0.01),与西药对照组(联苯苄唑凝胶)作用相当,但强于N-9组,且差异有统计学意义(P<0.05)。JZ2中、低剂量凝胶组预防率较低,但与模型组之间的差异有统计学意义(P<0.05)。结论:体外实验中JZ2(含JZ17.8mg,N-90.78mg)即可抑制念珠菌的生长;JZ2凝胶对白色念珠菌性阴道炎具有较好的预防作用。 相似文献
993.
Erim Y Beckmann M Kroencke S Schulz KH Tagay S Valentin-Gamazo C Malago M Frilling A Broelsch CE Senf W 《Clinical transplantation》2008,22(3):273-280
Abstract: The protection of the donors from physical or emotional harm has been a fundamental principle in living-donor liver donation from the beginning. Psychosomatic donor evaluation aims at the selection of eligible donors and the screening and exclusion of psychiatrically vulnerable donors. As clinical interviews may include subjective biases, efforts should be made to establish objective criteria for donor assessment. In recent research, protective factors have been reported to be a significant force behind healthy adjustment to life stresses and can be investigated as possible predictors of donors' eligibility. Being the central construct of Antonovsky's theory of salutogenesis, the sense of coherence is one of the most surveyed protective factors and a good predictor of individuals' stability when experiencing stress. Furthermore, family support has been shown to be a valuable protective resource in coping with stress. This study surveyed whether sense of coherence and social support predict donors' emotional strain prior to transplantation. Seventy-one donor candidates were included in the study during the donor evaluation prior to living-donor liver transplantation. Sense of coherence proved to be a significant predictor for all criterion variables, namely anxiety, depression and mental quality of life. In addition to this, donor candidates who were classified as eligible for donation in the psychosomatic interview had significantly higher values on sense of coherence total scores compared with rejected donors. In a multiple regression analysis, sense of coherence and social support together yielded a prediction of depression with an explained variance of 22% ( R 2 = 0.22). Sense of coherence and social support can be implemented as self-rating instruments in the psychosomatic selection of donors and would help to further objectify donors' eligibility. 相似文献
994.
Abstract: Introduction: To maximize organ utilization, the United Network for Organ Sharing (UNOS) encourages use of Expanded Criteria Donors (ECD). However, Standard Criteria Donors (SCD) may also be under‐utilized, some centers discarding kidneys with serum creatinine (S.Cr) >2.0 at nephrectomy. Our experience with the use of such ``impaired’’ kidneys was reviewed retrospectively. Results: From January 1, 2003 to October 1, 2006, of 130 DD kidneys transplanted at our center, 26 were ECD. Also, 22 kidneys were from Impaired SCD (ISCD), with mean S.Cr 3.2 (2.1–4.4) at nephrectomy; eight of these had S.Cr >4.0. For these 22 ISCD, mean age was 22 yrs (11–42), sex: 16 Males; race:12 Caucasians/10 African‐Americans; All had evidence of rhabdomyolysis (Mean peak CPK 11,924 u/l). Thirty‐seven percent came from outside OPOs. Recipient demographics: age 45 years; sex 50% male, 45% African‐American. Mean HLA match was 1; dialysis was required in 28% within the first week. Mean length of stay was 10.7 days. Average discharge S.Cr was 4.2. All kidneys are currently functioning (S.Cr at 3 months, 6 months and 1 year 1.6, 1.7 and 1.7 respectively). Conclusion: An elevated creatinine should not be the only cause for discarding deceased donor kidneys. 相似文献
995.
Huurman VA Baranski AG Groeneveld JH Keizer KM Schaapherder AF 《Clinical transplantation》2008,22(6):847-850
A 71-yr-old male kidney transplant recipient suffered from delayed graft function. Eighty days after transplantation complete obstruction of the proximal ureter was observed, complicated by recurrent urinary tract infections. Two months later, the donor kidney was removed because of infectious complications and inadequate arterial perfusion. Histological examination of the removed graft showed signs of rejection as well as a low-grade papillary urothelial cell carcinoma of donor origin in the ureter. The remaining donor ureter was removed subsequently and showed no further signs of malignancy. Follow-up of the patient until 12 months after surgery did not reveal recurrence of the tumor. This case report is the first to describe accidental transfer of urothelial cell carcinoma in the ureter by transplantation, highlighting the possibility of malignancy when early stenosis is not related to the anastomosis. It again emphasizes the need for precise and cautious screening of organ donors, especially those of higher age. 相似文献
996.
Polak WG Peeters PM Miyamoto S Sieders E de Jong KP Porte RJ Bijleveld CM Hendriks HG Tenvergert EM Slooff MJ 《Clinical transplantation》2008,22(2):171-179
Abstract: Between November 1982 and March 2006, 67 children with body weight ≤10 kg had a primary liver transplantation from deceased donors in our unit. The aim of this study was to analyze the outcome in terms of patient and graft survival and to search for factors affecting this outcome. Overall, one-, three-, five-, and 10-yr primary patient and graft survival rates were 73%, 71%, 66%, 63% and 59%, 56%, 53%, 48%, respectively. Twenty-four of 67 (36%) children died and in the remaining 22 (33%), the first grafts failed and they were retransplanted. Cox regression analysis revealed that a need for retransplantation and urgent transplantation were important predictors for patient survival (p = 0.04 and p = 0.001, respectively). To assess whether the need for retransplantation can be influenced, all study variables were compared between surviving grafts and failed grafts. Cox regression analysis showed that only donor/recipient (D/R) weight ratio proved to be independent predictor for graft survival (p = 0.004). After comparison of graft survival with the long rank test according to different D/R weight ratios (3.0–7.0), the cut-off point for significantly different graft survival approached 4.0. The one-, three-, five-, and 10-yr graft survival for technical variant grafts with a D/R weight ratio <4.0 was 85%, 68%, 68%, and 68% compared with a D/R weight ratio >4.0 was 44%, 38%, 38%, and 30%, respectively (p = 0.02). In summary, patient survival in children with body weight ≤10 kg is determined by urgent transplantation and the need for retransplantation. Graft loss and retransplantation in small children can be prevented by adequate size matching of donor and recipient whereby a D/R weight ratio <4.0 seems to offer the favorable outcome. 相似文献
997.
Meguro M Soejima Y Taketomi A Ikegami T Yamashita Y Harada N Itoh S Hirata K Maehara Y 《Surgery today》2008,38(5):463-468
We herein present a case of unresectable giant hepatic hemangiomas with Kasabach-Merritt syndrome which was successfully treated
by living donor liver transplantation using a left lobe graft. The patient was a 45-year-old woman who complained of abdominal
distension. Two sessions of transarterial embolization were performed, but failed to reduce the size of the tumor. The hepatic
tumors were thus judged untreatable and the only option for a cure was to offer living donor liver transplantation, because
of the tumor size, its location, and the association with Kasabach-Merritt syndrome. A left lobe graft with the middle hepatic
vein donated by her 47-year-old brother was transplanted under venovenous bypass. The postoperative course of the recipient
was complicated by small-for-size graft syndrome, which developed after episodes of acute cellular rejection on postoperative
day 8 and sepsis on day 31. The patient successfully recovered from the complications and was discharged on day 72, and she
remains well at 10 months after transplantation. In conclusion, living donor liver transplantation was found to be an effective
option for the treatment of a patient with unresectable giant hepatic hemangiomas complicated by Kasabach-Merritt syndrome. 相似文献
998.
999.
Komatsu T Sakurada C Sasaki M Sanai K Tsuzuki M Bagetta G Sakurada S Sakurada T 《Neuropharmacology》2007,52(5):1237-1243
Intrathecal (i.t.) administration of morphine at a high dose of 60nmol into the spinal lumbar space in mice produces a severe hindlimb scratching followed by biting and licking. Nitric oxide (NO) is thought to play an important role in signal transduction pathways that enhance nociceptive transmission in the spinal cord. The present study was designed to determine whether high-dose i.t. morphine could influence the activation of the extracellular signal-regulated kinase (ERK), a mitogen-activated protein (MAP) kinase in neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS) activation. Both 7-NI and TRIM, selective inhibitors of nNOS, resulted in a dose-dependent inhibition of high-dose i.t. morphine-induced behavior. The selective iNOS inhibitor W1400 in relatively large doses inhibited in a non dose-dependent manner. The i.t. injection of morphine evoked a definite activation of ERK in the lumbar dorsal spinal cord. Behavioral experiments showed that U0126 (0.5-2.5nmol), a MAP kinase-ERK inhibitor, dose-dependently attenuated the behavioral response to i.t. morphine. In mice treated with high-dose morphine, 7-NI was very effective in blocking ERK activation, whereas W1400 had no effect. Taken together, these results suggest that the behavioral response to high-dose i.t. morphine may be triggered by the nNOS-ERK pathway in the dorsal spinal cord. 相似文献
1000.